The Quantellect read.As of Nov 19, 2026, 5 active firms cover AMN Healthcare Services Inc: 3 rate it Buy or better, 2 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets span $26.00 to $43.00, a moderate spread. The average target of $36.80 sits 2% below the current $37.63. Sentiment has drifted a little more constructive lately, with Sell ratings easing from 1 to 0 over recent months. On the fundamentals, the Street sees revenue growth near 19% this year and -19% next, consensus EPS building from about $0.20 next quarter toward $0.94 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 active firms
Buy
Strong Buy00%
Buy360%
Neutral240%
Sell00%
Strong Sell00%
Based on 5 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$36.80
-2.2% downside
Average target across 5 active firms as of Nov 19, 2026 vs $37.63 current
Highest Target$43.00
Average Target$36.80
Lowest Target$26.00
Detailed analyst forecasts for AMN
Showing 1–5 of 5 named analysts shown · 5 active firms in the rating projection
As of Nov 19, 2026, 3 of 5 active firms rate AMN a Buy (2 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
AMN EPS & revenue forecast
EPS · NEXT QUARTER
$0.20
Range $0.14 – $0.29 · 7 analysts · -91% YoY
Next period, 7 analysts expect AMN Healthcare Services Inc to earn $0.20 a share (range $0.14 – $0.29), versus $2.10 a year earlier. Full-year consensus is $4.19, growing to $0.94 the year after.
REVENUE · NEXT QUARTER
$671.6M
Range $657.1M – $689.3M · 7 analysts · -1% YoY
Revenue is expected to reach $671.6M (range $657.1M – $689.3M), -1.0% year-over-year. Full-year consensus is $3.4B, rising to $2.7B next year.
Top analysts covering AMN Healthcare Services Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on AMN.
#1
BS
Bill Sutherland
Benchmark · Rank #48
Neutral
No targeton AMN
Overall win rate
46%
+ Follow
#2
AR
A.J. Rice
UBS · Rank #365
Neutral
$35.00-7.0% to target
Overall win rate
35%
+ Follow
#3
Jeffrey Silber
BMO Capital · Rank #397
Buy
$43.00+14.3% to target
Overall win rate
30%
+ Follow
#4
Tobey Sommer
Truist Securities · Rank #445
Buy
No targeton AMN
Overall win rate
36%
+ Follow
#5
Constantine Davides
JMP Securities · Rank #454
Buy
$51.00+35.5% to target
Overall win rate
32%
+ Follow
AMN stock forecast FAQ
What is AMN's average 12-month price target?+
The 5 active firms with a live target average $36.80 for AMN Healthcare Services Inc over the next 12 months, ranging from a $43.00 high to a $26.00 low, as of Nov 19, 2026.
Is AMN stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 5 active firms as of Nov 19, 2026, 3 rate it Buy or Strong Buy, 2 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for AMN?+
The Street-high target is $43.00 (BMO Capital), and the Street-low is $26.00 (Baird). The average of all 5 active-firm targets is $36.80.
How many active Wall Street firms cover AMN?+
5 active firms have a recognized rating on AMN Healthcare Services Inc as of Nov 19, 2026, and 5 active firms carry a live 12-month price target.
Who is the most accurate analyst covering AMN?+
Among analysts who currently cover AMN, Bill Sutherland of Benchmark has the strongest overall Quantellect track record (Rank #48). Their current call is Neutral.
What is AMN Healthcare Services Inc's projected EPS for next quarter?+
The consensus estimate is $0.20 per share (range $0.14 – $0.29) across 7 analysts. Full-year EPS is projected at $4.19, rising to $0.94 the following year.
How much revenue is AMN Healthcare Services Inc expected to report next quarter?+
Consensus revenue is $671.6M (range $657.1M – $689.3M). Full-year revenue is projected at $3.4B, growing to $2.7B next year.
Have analysts been upgrading or downgrading AMN lately?+
As of Nov 19, 2026, 3 of 5 active firms rate AMN a Buy (2 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their AMN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.